Benitec Biopharma Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BNTC, updated each market day.
BNTC AI Sentiment
AI predicts Benitec Biopharma Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Oct. 9, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Sector
Exchange
Market Cap
$334,176,515
Cap Tier
Employees
24
Headquarters
HAYWARD, CA
Listed Since
July 11, 2012
Website
BNTC Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BNTC Volatility
Benitec Biopharma Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
